"safety and efficacy" trang 11 - tải miễn phí từ tailieunhanh
Efficacy and safety of three - dimensional laparoscopic adrenalectomy: A single-center experience

Efficacy and safety of three - dimensional laparoscopic adrenalectomy: A single-center experience
6    1    1
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours

Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours
14    2    1
Efficacy and safety analysis of TACE+sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: A retrospective study

Efficacy and safety analysis of TACE+sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: A retrospective study
11    5    1
Efficacy and safety of transurethral resection of bladder tumour combined with chemotherapy and immunotherapy in bladder-sparing therapy in patients with T1 high-grade or T2 bladder cancer: A protocol for a randomized controlled trial

Efficacy and safety of transurethral resection of bladder tumour combined with chemotherapy and immunotherapy in bladder-sparing therapy in patients with T1 high-grade or T2 bladder cancer: A protocol for a randomized controlled trial
8    4    1
Efficacy and safety of PD-1/PD-L1 inhibitors combined with anti-angiogenic therapy for the unresectable hepatocellular carcinoma and the benefit for hepatitis B virus etiology subgroup: A systematic review and meta-analysis of randomized controlled trials

Efficacy and safety of PD-1/PD-L1 inhibitors combined with anti-angiogenic therapy for the unresectable hepatocellular carcinoma and the benefit for hepatitis B virus etiology subgroup: A systematic review and meta-analysis of randomized controlled trials
11    6    1
Efficacy and safety of dacomitinib in treatment-naïve patients with advanced NSCLC harboring uncommon EGFR mutation: An ambispective cohort study

Efficacy and safety of dacomitinib in treatment-naïve patients with advanced NSCLC harboring uncommon EGFR mutation: An ambispective cohort study
10    6    1
Efficacy and safety of endoscopic retrograde cholangiopancreatography for the treatment of acute biliary pancreatitis with or without cholangitis

Efficacy and safety of endoscopic retrograde cholangiopancreatography for the treatment of acute biliary pancreatitis with or without cholangitis
6    1    1
Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis

Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis
8    1    1
Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection

Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection
9    2    1
Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinumcontaining regimens: A systematic review and meta-analysis

Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinumcontaining regimens: A systematic review and meta-analysis
12    4    1
Efficacy and safety analysis of TACE+Donafenib+Toripalimab versus TACE+Sorafenib in the treatment of unresectable hepatocellular carcinoma: A retrospective study

Efficacy and safety analysis of TACE+Donafenib+Toripalimab versus TACE+Sorafenib in the treatment of unresectable hepatocellular carcinoma: A retrospective study
11    8    1
Efficacy and safety of venetoclax in patients with relapsed/refractory multiple myeloma: A meta-analysis

Efficacy and safety of venetoclax in patients with relapsed/refractory multiple myeloma: A meta-analysis
9    3    1
Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: A prospective single-arm trial (MiroCIP study)

Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: A prospective single-arm trial (MiroCIP study)
11    3    1